Mankind Pharma Ltd
NSE:MANKIND
Mankind Pharma Ltd
Operating Income
Mankind Pharma Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Operating Income
₹21.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Operating Income
₹64.6B
|
CAGR 3-Years
25%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Operating Income
₹52.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
21%
|
CAGR 10-Years
12%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Operating Income
₹101.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
13%
|
CAGR 10-Years
5%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Operating Income
₹45.4B
|
CAGR 3-Years
18%
|
CAGR 5-Years
14%
|
CAGR 10-Years
16%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Operating Income
₹24.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
See Also
What is Mankind Pharma Ltd's Operating Income?
Operating Income
21.4B
INR
Based on the financial report for Mar 31, 2024, Mankind Pharma Ltd's Operating Income amounts to 21.4B INR.
What is Mankind Pharma Ltd's Operating Income growth rate?
Operating Income CAGR 3Y
11%
Over the last year, the Operating Income growth was 35%. The average annual Operating Income growth rates for Mankind Pharma Ltd have been 11% over the past three years .